Thompson Investment Management, Inc. Abb Vie Inc. Transaction History

Thompson Investment Management, Inc.

$677 Million
Q3 2024

A detailed history of Thompson Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 39,013 shares of ABBV stock, worth $7.08 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares

39,013

Previous 38,826 0.48%

Holding current value

$7.08 Million

Previous $6.66 Million 15.69%

% of portfolio

1.14%

Previous 1.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$163.84 - $199.33 $30,638 - $37,274	187 Added 0.48%	39,013 $7.7 Million
Q2 2024 Jul 08, 2024	SELL	$154.79 - $180.76 $17,800 - $20,787	-115 Reduced 0.3%	38,826 $6.66 Million
Q1 2024 Apr 12, 2024	SELL	$159.82 - $182.1 $58,653 - $66,830	-367 Reduced 0.93%	38,941 $7.09 Million
Q4 2023 Jan 16, 2024	SELL	$137.6 - $154.97 $54,627 - $61,523	-397 Reduced 1.0%	39,308 $6.09 Million
Q3 2023 Oct 30, 2023	SELL	$133.59 - $154.65 $77,615 - $89,851	-581 Reduced 1.44%	39,705 $5.92 Million
Q2 2023 Jul 10, 2023	BUY	$132.51 - $164.9 $276,150 - $343,651	2,084 Added 5.46%	40,286 $5.43 Million
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $201,441 - $231,990	-1,393 Reduced 3.52%	38,202 $6.09 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $205,528 - $246,482	-1,486 Reduced 3.62%	39,595 $6.4 Million
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $295,664 - $339,107	-2,203 Reduced 5.09%	41,081 $5.51 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $572,499 - $727,833	-4,160 Reduced 8.77%	43,284 $6.63 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $569,493 - $706,581	-4,315 Reduced 8.34%	47,444 $7.69 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $662,198 - $837,872	-6,164 Reduced 10.64%	51,759 $7.01 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $103,952 - $118,002	977 Added 1.72%	57,923 $6.25 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $55,340 - $61,652	-526 Reduced 0.92%	56,946 $6.41 Million
Q1 2021 Apr 07, 2021	BUY	$102.3 - $112.62 $79,282 - $87,280	775 Added 1.37%	57,472 $6.22 Million
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $91,597 - $123,666	1,138 Added 2.05%	56,697 $6.08 Million
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $233,503 - $274,055	-2,718 Reduced 4.66%	55,559 $4.87 Million
Q2 2020 Jul 23, 2020	SELL	$73.37 - $98.18 $142,557 - $190,763	-1,943 Reduced 3.23%	58,277 $5.72 Million
Q1 2020 Apr 23, 2020	SELL	$64.5 - $97.79 $109,392 - $165,851	-1,696 Reduced 2.74%	60,220 $4.59 Million
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $243,005 - $304,052	-3,369 Reduced 5.16%	61,916 $5.48 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $124,196 - $149,319	1,972 Added 3.11%	65,285 $4.94 Million
Q2 2019 Aug 07, 2019	BUY	$65.7 - $83.98 $102,492 - $131,008	1,560 Added 2.53%	63,313 $4.6 Million
Q1 2019 Apr 24, 2019	BUY	$77.14 - $90.79 $80,997 - $95,329	1,050 Added 1.73%	61,753 $4.98 Million
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $254,102 - $313,376	-3,264 Reduced 5.1%	60,703 $5.6 Million
Q3 2018 Nov 06, 2018	SELL	$88.91 - $98.84 $15,203 - $16,901	-171 Reduced 0.27%	63,967 $6.05 Million
Q2 2018 Jul 09, 2018	BUY	$89.78 - $106.23 $11,761 - $13,916	131 Added 0.2%	64,138 $5.94 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $463,270 - $620,362	-5,035 Reduced 7.29%	64,007 $6.06 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $367,822 - $403,348	-4,107 Reduced 5.61%	69,042 $6.68 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $5.11 Million - $6.53 Million	73,149	73,149 $6.5 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Investment Management, Inc. with notifications on news.

Account

Thompson Investment Management, Inc. Abb Vie Inc. Transaction History